Berberine ameliorates the progression of primary sclerosing cholangitis by activating farnesoid X receptor
-
Published:2024-02-08
Issue:2
Volume:82
Page:767-776
-
ISSN:1085-9195
-
Container-title:Cell Biochemistry and Biophysics
-
language:en
-
Short-container-title:Cell Biochem Biophys
Author:
Hameed Hassan,Irshad Nida,Yousaf Muhammad Abrar,Mumtaz Sidra,Sohail Imran
Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. Fickert, P., Pollheimer, M. J., Beuers, U., Lackner, C., Hirschfield, G., Housset, C., Keitel, V., Schramm, C., Marschall, H. U., Karlsen, T. H., Melum, E., Kaser, A., Eksteen, B., Strazzabosco, M., Manns, M., & Trauner, M. (2014). Characterization of animal models for primary sclerosing cholangitis (PSC). Journal of Hepatology, 60, 1290–1303. 2. Eaton, J. E., Talwalkar, J. A., Lazaridis, K. N., Gores, G. J., & Lindor, K. D. (2013). Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology, 145, 521–536. 3. Lindor, K. D., Kowdley, K. V., Luketic, V. A., Harrison, M. E., McCashland, T., Befeler, A. S., Harnois, D., Jorgensen, R., Petz, J., Keach, J., Mooney, J., Sargeant, C., Braaten, J., Bernard, T., King, D., Miceli, E., Schmoll, J., Hoskin, T., Thapa, P., & Enders, F. (2009). High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology, 50, 808–814. 4. Giljaca, V., Poropat, G., Stimac, D., & Gluud, C. (2010). Glucocorticosteroids for primary sclerosing cholangitis. The Cochrane Database of Systematic Reviews, 2010, Cd004036. 5. Mousavere, I., Kalampokis, G., Fousekis, F., Karayiannis, P., Baltayiannis, G., & Christodoulou, D. (2023). An overview of recent treatment options for primary sclerosing cholangitis. Annals of Gastroenterology, 36, 589–598.
|
|